Abstract
It remains unclear whether the rate of fetal death has changed during the COVID-19 pandemic. We assessed the impact of COVID-19 mitigation measures on fetal death in Sweden (449,347 births), Denmark (290,857 pregnancies) and Norway (261,057 pregnancies) using robust population-based registry data. We used Cox regression to assess the impact of the implementation of pandemic mitigation measures on March 12th, 2020, on miscarriage (fetal loss before gestational week 22) and stillbirth (fetal loss after gestational week 22). A total of 11% of 551,914 pregnancies in Denmark and Norway ended in miscarriage, while the proportion of stillbirths among 937,174 births across the three countries was 0.3%. There was no difference in the risk of fetal death during the year following pandemic mitigation measures. For miscarriage, the combined hazard ratio (HR) for Norway and Denmark was 1.01 (95% CI 0.98, 1.03), and for stillbirth, the combined HR for all three countries was 0.99 (95% CI 0.89, 1.09). We observed a slightly decreased risk of miscarriage during the first 4 months, with an HR of 0.94 (95% CI 0.90, 0.99) after lockdown. In conclusion, the risk of fetal death did not change after the implementation of COVID-19 pandemic mitigation measures in the three Scandinavian countries.
Subject terms: Medical research, Epidemiology
The COVID-19 pandemic has had broad social, economic and health-related impacts1,2. It was suggested early on that pandemic mitigation measures could influence the rate of pregnancy outcomes; however, whether this is the case is controversial due to inconsistent findings across countries3. Some studies report evidence of an increase in stillbirths during the first wave of the pandemic4–9, while other studies found no evidence of a difference10–17. A meta-analysis concluded that there was significant evidence of an increase in stillbirths after pandemic lockdown18. The majority of the existing studies had a limited sample size, with fewer than 30 stillbirth cases after the onset of the pandemic4,6,10–12. The largest study to date used information on more than 400,000 births during the pandemic identified through National Health Service hospital admissions in England and indicated no difference in the rate of stillbirth after the start of the pandemic19. There are no existing studies that compare the rate of miscarriage following pandemic lockdown to rates during the prepandemic period.
The Scandinavian countries, Sweden, Denmark and Norway, are similar with regard to their universal healthcare, levels of income inequality, and fertility patterns. When the World Health Organization declared that COVID-19 had reached a pandemic level (March 13, 2020), the number of infected persons was relatively low in all three Scandinavian countries. Denmark and Norway initiated strict pandemic mitigation measures in mid-March in an attempt to avoid the high burdens on the health-care systems observed across several other European countries, while Sweden followed a less strict approach20–22. There were clear changes in the behaviour of the populations in all three countries from mid-March, resulting in a decreased use of public transportation, less workplace commuting and more time spent at home23. Behavioural measures indicated that the strict lockdowns of Denmark and Norway resulted in more drastic behavioural changes than in Sweden24. We hypothesized that the pandemic mitigation measures could plausibly decrease the risk of fetal death, as pregnant women were likely to have less exposure to infections25,26.
The objective of this study was to assess the impact of COVID-19 mitigation measures on the risk of fetal death using national registry-based data from Sweden, Denmark and Norway.
Materials and methods
Study population
We extracted information on pregnancies registered with a live birth, stillbirth or miscarriage between January 2017 and March 2021. In Denmark and Norway, information was available from national Medical Birth Registers and National Patient Registers and included all pregnancies resulting in any contact with specialist health-care services (also referred to as secondary/tertiary). The data from Denmark and Norway therefore included all births (live and stillbirths), in addition to all recognized miscarriages resulting in contact with specialist health-care services. This is likely to include the overwhelming majority of recognized first-trimester miscarriages and all second trimester miscarriages. In Norway, the exact gestational age of the first-trimester miscarriages occurring before 12 completed gestational weeks was not available. Based on registrations in Denmark, the median gestational week of the registered first-trimester miscarriages was 8 weeks (interquartile range 6, 9). From the Swedish Pregnancy Register, we retrieved information on all births at ≥ 22 gestational weeks during the same time period; in Sweden, 92% of births are included in the national register (18 of 21 Swedish regions). We therefore had information on all registered pregnancies for Denmark and Norway, while we only had information on births for Sweden. Further details of the data sources are listed in the appendix (supplementary online methods). This study was approved by the Regional Committee for Medical and Health Research Ethics of South/East Norway (#141135) and the Swedish Ethical Review Authority (approval numbers: dnr 2020-01499, dnr 2020-02468, dnr 2021-00274). Denmark, the study was registered with the Danish Data Protection Agency via the University of Southern Denmark (reg. no. 364 20/17416) and via Statistics Denmark. Each committee provided a waiver of consent for participants. The ethical committees mentioned above in the three Nordic countries are grounded in foundational ethical principles embodied in the Declaration of Helsinki of 1964 and its subsequent revisions and the Belmont Report.
Pandemic mitigation
Although the intensity and timing of COVID-19 mitigation measures differed between the three countries, the majority of measures were introduced around March 12th, 2020 (Table 1). Thus, March 12th, 2020, was taken as the common date for the introduction of pandemic mitigation measures (“lockdown”) across all three countries. The exposure of interest was therefore pregnancy days after this date. Notably, Norway and Denmark had an overall very similar approach to the implementation of pandemic mitigation measures. These two countries implemented similar strict measures around the same time. In contrast, Sweden had fewer and less strict pandemic mitigation measures. The details of the specific measures are described in Table 1.
Table 1.
Sweden | Denmark | Norway | |
---|---|---|---|
Daycare and primary schools closed | n/a | March 16 | March 12 |
High school and universities closed | March 17 (recommendation) | March 13 | March 12 |
Restrictions on gathering |
March 11 (500+) March 27 (50+) |
March 11 (100+) March 17 (10+) |
March 12 |
Home office recommendations | March 16 (recommendation to use home office) | March 13 (Non-essential workers in public sector ordered to stay home, private sector urged to permit use of home office) | March 10 (recommendation to use home office) |
Non-essential business closed | Some closures from March 18, including restaurants/bars | Some closures from March 12 | |
Recommendations to stay at home |
March 16 for over 70 s March 19 Avoid unnecessary travels |
March 11 restrict public transport and unnecessary travels |
March 12 Avoid public transport and unnecessary travels, March 19 not allowed to spend night in vacation homes outside home county |
Regulation of internal (domestic) movement | March 19 | April 9 | March 12 |
International travel restrictions |
March 14 Advice against all unnecessary international travels, isolation and get tested if symptoms after arrival to Sweden |
March 11 (flights from high-risk areas cancelled) March 14 (all borders closed) |
March 13 Recommendations to avoid all unnecessary international travel, mandatory quarantine when arriving Norway, isolation if symptoms |
Public events cancelled | March 12 | March 13 | March 12 |
Fetal death
We defined fetal death as miscarriage or stillbirth based on gestational age, where fetal deaths with a gestational age ≥ 22 weeks were defined as stillbirths. In Denmark, pregnancies were identified using the Medical Birth Registry (including fetal deaths after 22 completed gestational weeks and all live births) and the national Patient Registry (for fetal death before 22 weeks). For Norway, the Medical Birth Registry included all pregnancies ending after 12 completed gestational weeks, while information on pregnancies ending prior to this time was obtained through the National Patient Registry. In Sweden, we obtained information on deliveries after 22 completed gestational weeks from the Pregnancy Register. Further details on the identification of pregnancies across the three different countries are available in the supplemental methods. We examined the risk of miscarriage only in Denmark and Norway, while the risk of stillbirth was examined in all three countries.
In Denmark, information on all pregnancies was available from the National Patient Registry and the Danish Medical Birth Register27,28. The Danish Medical Birth Register includes all births up to December 31, 2018, but only a proportion of births from the first quarter of 2019. Therefore, from January 1, 2019, we identified live births based on registrations of International Classification of Disease version 10 (ICD-10) codes Z38 and O80-84, and stillbirths based on registrations of ICD-10 code P95 in the National Patient Registry. Any registration of stillbirths with a birthweight of < 500 g and where gestational age was missing or less than 22 weeks was reclassified as miscarriages. Miscarriages were further identified using ICD-10 codes O02- “spontaneous abortion” and O03- “other abnormal products of conception”. In Norway, information on all pregnancies ending after 12 completed gestational weeks was available from the Medical Birth Registry of Norway29. All pregnancies recorded in the birth registry are designated as either having resulted in a live birth or a fetal death. We distinguished fetal deaths according to whether they were a miscarriage or a stillbirth based on information on birthweight and gestational age. We defined a fetal death as a miscarriage if the gestational age was < 22 completed weeks and the birthweight was < 500 g, while a fetal death with a gestational age ≥ 22 completed gestational weeks or a birthweight ≥ 500 g was classified as a stillbirth. Information on miscarriages prior to 12 completed gestational weeks was available from the patient registry30. As in Denmark, we used the ICD-10 codes O02 and O03 to identify miscarriages. In Sweden, we had information on all deliveries (live and stillbirths) after 22 completed gestational weeks from the Swedish Pregnancy Register. This quality register was initiated in 2013 and includes 92% of all births in Sweden (18 of 21 regions).
Statistical analysis
Individual-level data were analysed for each country separately. We examined differences in the risk of miscarriage and stillbirth using Cox proportional hazards regression with the gestational day as the time metric. We chose to use a Cox regression to distinguish between the time of the pregnancy that was pre-pandemic as opposed to during the pandemic. To avoid oversampling of short pregnancies and fetal losses towards the end of the study period, we excluded all pregnancies that did not have the opportunity to reach 42 completed gestational weeks by the end of follow-up based on the best estimate of the start of pregnancy, prioritising ultrasound measurements where this was available. Exposure to pandemic mitigation measures (e.g., pregnancy days after March 12th 2020) was used as a time-varying exposure, derived using gestational day on the implementation of pandemic mitigation measures (March 12th, 2020). Women could therefore contribute both exposed and unexposed follow-up time if their pregnancy started before and ended after March 12th, 2020. We adjusted for calendar week as a discrete variable to account for seasonal variation in the risk of the outcomes of interest. We examined the validity of the proportional hazards assumption by visually inspecting the Schoenfeld residuals. The results from each country were subsequently combined using a random effects meta-analysis. As the individual-level datasets were housed at independent institutions in the three countries, it was not possible to conduct a pooled analysis of the individual-level data and test differences between the countries using an interaction term. Heterogeneity was instead assessed using the I2 statistic, calculated as 100% × (Q–df)/Q, where Q is Cochrane's heterogeneity statistic and df denotes degrees of freedom31. The main analysis examined whether the implementation of pandemic mitigation measures on March 12th, 2020, influenced the risk of fetal death during a 12-month follow-up period. Secondary analyses examined more immediate effects of the implementation of the pandemic mitigation measures during the 2, 4 and 6 months following March 12th, 2020. Analyses were performed using Stata version 16 (Statacorp, Texas).
Results
A total of 449,347 births were recorded in Sweden during the study period, while 290,857 pregnancies (257,733 births) were recorded in Denmark, and 261,057 pregnancies (230,094 births) were recorded in Norway. The overall proportion of miscarriage among all pregnancies during the follow-up period was 11.4% in Denmark and 11.9% in Norway. Among all births, the proportion ending in stillbirth was 0.3% in all three countries. The proportion of stillbirth and miscarriage remained relatively stable in all three countries during the prepandemic study period.
Trends in miscarriage in Denmark and Norway
The proportion of pregnancies ending in a miscarriage was highest during the peak winter months and lowest during summer (Fig. 1). These seasonal variations were observed for all calendar years in both Denmark and Norway. The survival analysis indicated no increased risk of miscarriage during the 12 months following the implementation of the pandemic mitigation measure, with a combined HR of 1.01 (95% CI 0.98, 1.03) and no evidence of heterogeneity between countries (I2 0%, p value 0.39) (Fig. 2). We observed a modestly decreased risk of miscarriage during the first 2 months (combined HR 0.93; 95% CI 0.88, 0.98) and first 4 months (combined HR 0.94; 95% CI 0.90, 0.99) following the implementation of the pandemic mitigation measures (Fig. 2). A corresponding decreased risk was not observed for the 6-month time window.
Trends in stillbirth in Denmark, Norway and Sweden
Compared to seasonal variations in miscarriage, seasonal trends in stillbirth were much less pronounced (Fig. 3). There was no increased rate of stillbirth during the 12 months following the implementation of pandemic mitigation measures, with a combined HR of 0.99 (95% CI 0.89, 1.09), and no heterogeneity in the associations across countries (I2 0%, p value 0.78) (Fig. 4). Similarly, there was no indication of more short-term impacts of the pandemic mitigation measures during the first 2 (combined HR 1.02; 95% CI 0.81, 1.27), 4 (combined HR 0.95; 0.81, 1.11) and 6 (combined HR 0.99; 95% CI 0.87, 1.13) months’ time windows.
Discussion
Using national registries from Sweden, Denmark and Norway, we found no increase in fetal death after the implementation of COVID-19 pandemic mitigation measures across three Scandinavian countries. We observed a modest decreased risk of miscarriage during the first 4 months following March 12th, 2020.
Some existing studies suggest an increase in stillbirths following COVID-19 pandemic mitigation measures4–9, but the evidence is inconsistent10–17. As the majority of the existing studies have a very small sample size (with between 20 and 140 cases of stillbirth after lockdown), there is a high degree of uncertainty in the estimates. A meta-analysis of 6 studies suggested an increased risk of stillbirth during the first wave of the pandemic, with a combined incidence rate ratio of 1.33 (95% CI 1.04, 1.69)18. Differences in the findings across studies could be due to variations in the sample size, the country income level, financing of the health-care system, and the extensiveness of pandemic mitigation measures. Two of the previous studies included in the meta-analysis had ~ 140 cases of stillbirth after lockdown5,7, while the rest of the studies had only approximately 20 cases of stillbirth after lockdown or less4,6,10–12. The largest study to date (more than 130,000 births and 543 cases of stillbirth after lockdown) from the UK had a clear null finding, similar to that observed across the three countries in our study, with a risk of 0.36% during the pandemic versus 0.37% during the prepandemic period (p = 0.16)19.
To our knowledge, studies examining the change in the risk of miscarriage after the implementation of pandemic mitigation measures are lacking.
There are several well-known risk factors for miscarriage32–35 and stillbirth36–38, although understanding of the biological mechanisms remains inadequate. Our findings are reassuring given that general access to health care among pregnant women was reduced during the early stages of the pandemic. There are a number of potential explanations for how pandemic mitigation measures could plausibly contribute to a modest decreased risk of miscarriage. For example, certain infectious diseases are associated with an increased risk of miscarriage26, and a reduced number of social contacts (as a result of pandemic restrictions) may have led to fewer infections (not only COVID-19) among pregnant women. It is also possible that pandemic restriction measures resulted in less physical stress, which again could have reduced women’s risk of miscarriage, although the impact on work-related physical strain on the risk of miscarriage is likely to be modest25. However, the fact that we observed this modest decreased risk of miscarriage only during the first months after implementation of pandemic mitigation measures might also indicate that this modest reduction is unlikely to be causal. For example, if a larger proportion of miscarriages was seen only in primary care (and not referred to specialist health-care services) during this rather chaotic time, this could also explain this finding. The lack of a causal relationship between pandemic mitigation measures and risk of fetal death is further substantiated by the fact that we did not see any changes in stillbirth.
We studied more than one million pregnancies in the three Scandinavian countries from January 2017 through March 2021. The universal (free) health-care system in the Nordic countries and the mandatory registration of all contacts with the health-care system in the national registries ensured that we captured the majority of pregnancies during this period. For Norway and Denmark, all live and stillbirths (including home births) during the study period were included. For Sweden, we captured 92% of registered births (live and stillbirths), as information on approximately 8% of births is missing due to incomplete electronic data transfer in 3 of Sweden’s 21 counties39. The missing registrations did not depend on birth outcomes and would not bias associations. Information on early miscarriages registered in specialist health-care services in the Danish and Norwegian data at the population level is unique from an international perspective. For the Danish data, the introduction of new registration procedures during the study period may have led to inconsistencies in registration practices over time. Notably, we were only able to capture miscarriages resulting in contact with specialist health-care services. Very early miscarriages for which the woman did not seek health care or only contacted primary care services are therefore not captured. Based on previous estimates from the Norwegian general practitioner database, approximately ¼ of first-trimester miscarriages are only seen in primary care40. Therefore, our study will have underestimated the number of miscarriages. This could have contributed to our observation of a modest reduction in the number of miscarriages during the first months after the pandemic lockdown if a greater proportion of miscarriages were seen in the primary care during this time period because of a higher threshold for referring early miscarriages to specialist care during this early period.
The aim of our study was to assess the overall impact of pandemic mitigation measures on the rate of fetal death. We therefore did not include information on infection or vaccination for SARS-CoV-2. However, the current limited evidence indicates no strong evidence of an increased risk of fetal death among women who experienced SARS-CoV-2 infection during pregnancy41–44 or any evidence to support an increased risk of fetal death after vaccination45–47.
In conclusion, we observed no overall evidence of a change in the risk of miscarriage or stillbirth in the year following the implementation of pandemic mitigation measures across three Scandinavian countries.
Supplementary Information
Acknowledgements
This research was supported by NordForsk (project number 105545) and the Research Council of Norway through its Centres of Excellence funding scheme (project number 262700). M.C.M. has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 947684). L.H.M is supported in part by grants from the Novo Nordisk Foundation (NNF17OC0027594 and NNF17OC0027812). T.G.P is supported via funding awarded by the Danish Ministry of Higher Education and Science. The funders had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication.
Author contributions
M.C.M and S.E.H conceptualized the study. S.E.H, A.M.N.A and O.S. contributed to data acquisition. M.C.M., A.V.H. and A.K.Ö. conducted the data analysis and generated the tables and figures. M.C.M. drafted the initial version of the manuscript. L.L.O., T.G.P., L.H.M., M.B., A.M.N.A., O.S. and S.E.H. provided analytical oversight and edited the manuscript. All authors have read and agreed to the published version of the manuscript.
Data availability
The individual-level data that support the findings of this study are not publicly available due to legal restrictions in all three Scandinavian countries. The analytical code can be accessed by contacting the corresponding author.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-022-25036-1.
References
- 1.Wu S, et al. Aggressive containment, suppression, and mitigation of covid-19: Lessons learnt from eight countries. BMJ. 2021;375:e067508. doi: 10.1136/bmj-2021-067508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gebru AA, et al. Global burden of COVID-19: Situational analyis and review. Hum Antibodies. 2021;29:139–148. doi: 10.3233/hab-200420. [DOI] [PubMed] [Google Scholar]
- 3.Chmielewska B, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: A systematic review and meta-analysis. Lancet Global Health. 2021;9:e759–e772. doi: 10.1016/s2214-109x(21)00079-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.De Curtis M, Villani L, Polo A. Increase of stillbirth and decrease of late preterm infants during the COVID-19 pandemic lockdown. Arch Dis Child Fetal Neonatal Ed. 2021;106:456. doi: 10.1136/archdischild-2020-320682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kc A, et al. Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: A prospective observational study. Lancet Glob Health. 2020;8:e1273–e1281. doi: 10.1016/s2214-109x(20)30345-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Khalil A, et al. Change in the incidence of stillbirth and preterm delivery during the COVID-19 pandemic. JAMA. 2020;324:705–706. doi: 10.1001/jama.2020.12746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kumar M, et al. Stillbirths and the COVID-19 pandemic: Looking beyond SARS-CoV-2 infection. Int J Gynaecol Obstet. 2021;153:76–82. doi: 10.1002/ijgo.13564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kumari V, Mehta K, Choudhary R. COVID-19 outbreak and decreased hospitalisation of pregnant women in labour. Lancet Global Health. 2020;8:e1116–e1117. doi: 10.1016/s2214-109x(20)30319-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Muin DA, et al. Antepartum stillbirth rates during the COVID-19 pandemic in Austria: A population-based study. Int J Gynaecol Obstet. 2021 doi: 10.1002/ijgo.13989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Arnaez J, et al. Lack of changes in preterm delivery and stillbirths during COVID-19 lockdown in a European region. Eur J Pediatr. 2021;180:1997–2002. doi: 10.1007/s00431-021-03984-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gallo LA, et al. A decline in planned, but not spontaneous, preterm birth rates in a large Australian tertiary maternity centre during COVID-19 mitigation measures. Aust N Z J Obstet Gynaecol. 2021 doi: 10.1111/ajo.13406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Meyer R, et al. A marked decrease in preterm deliveries during the coronavirus disease 2019 pandemic. Am J Obstet Gynecol. 2021;224:234–237. doi: 10.1016/j.ajog.2020.10.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shakespeare C, Dube H, Moyo S, Ngwenya S. Resilience and vulnerability of maternity services in Zimbabwe: A comparative analysis of the effect of Covid-19 and lockdown control measures on maternal and perinatal outcomes, a single-centre cross-sectional study at Mpilo Central Hospital. BMC Pregnancy Childbirth. 2021;21:416. doi: 10.1186/s12884-021-03884-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Stowe J, et al. Stillbirths during the COVID-19 pandemic in England, April-June 2020. JAMA. 2021;325:86–87. doi: 10.1001/jama.2020.21369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kniffka MS, Nitsche N, Rau R, Kühn M. Stillbirths in Germany: On the rise, but no additional increases during the first COVID-19 lockdown. Int J Gynaecol Obstet. 2021;155:483–489. doi: 10.1002/ijgo.13832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Garabedian C, et al. Impact of COVID-19 lockdown on preterm births, low birthweights and stillbirths: A retrospective cohort study. J Clin Med. 2021 doi: 10.3390/jcm10235649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Simon E, et al. Impact of the COVID-19 pandemic on preterm birth and stillbirth: A nationwide, population-based retrospective cohort study. Am J Obstet Gynecol. 2021;225:347–348. doi: 10.1016/j.ajog.2021.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Vaccaro C, Mahmoud F, Aboulatta L, Aloud B, Eltonsy S. The impact of COVID-19 first wave national lockdowns on perinatal outcomes: A rapid review and meta-analysis. BMC Pregnancy Childbirth. 2021;21:676. doi: 10.1186/s12884-021-04156-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gurol-Urganci I, et al. Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study. PLoS Med. 2022;19:e1003884. doi: 10.1371/journal.pmed.1003884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ludvigsson JF. The first eight months of Sweden’s COVID-19 strategy and the key actions and actors that were involved. Acta Paediatr. 2020;109:2459–2471. doi: 10.1111/apa.15582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mens H, Koch A, Chaine M, Andersen ÅB. The Hammer versus Mitigation—A comparative retrospective register study of the Swedish and Danish national responses to the COVID-19 pandemic in 2020. APMIS. 2021;00:1–9. doi: 10.1111/apm.13133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yarmol-Matusiak EA, Cipriano LE, Stranges S. A comparison of COVID-19 epidemiological indicators in Sweden, Norway, Denmark, and Finland. Scand J Public Health. 2021;49:69–78. doi: 10.1177/1403494820980264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Roser, M., Ritchie, H., Ortiz-Ospina, E. & Hasell, J. Coronavirus Pandemic (COVID-19). (Accessed 26 April, 'https://ourworldindata.org/coronavirus' [Online Resource], 2020).
- 24.Zhang L, Brikell I, Dalsgaard S, Chang Z. Public mobility and social media attention in response to COVID-19 in Sweden and Denmark. JAMA Netw Open. 2021;4:e2033478–e2033478. doi: 10.1001/jamanetworkopen.2020.33478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bonde JP, Jørgensen KT, Bonzini M, Palmer KT. Miscarriage and occupational activity: A systematic review and meta-analysis regarding shift work, working hours, lifting, standing, and physical workload. Scand J Work Environ Health. 2013;39:325–334. doi: 10.5271/sjweh.3337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Heydarifard Z, et al. Potential role of viral infections in miscarriage and insights into the underlying molecular mechanisms. Congenit Anom (Kyoto) 2021 doi: 10.1111/cga.12458. [DOI] [PubMed] [Google Scholar]
- 27.Bliddal M, Broe A, Pottegård A, Olsen J, Langhoff-Roos J. The danish medical birth register. Eur J Epidemiol. 2018;33:27–36. doi: 10.1007/s10654-018-0356-1. [DOI] [PubMed] [Google Scholar]
- 28.Schmidt M, et al. The Danish National Patient Registry: A review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi: 10.2147/clep.S91125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Irgens LM. Medical birth registry–an essential resource in perinatal medical research. Tidsskr Nor Laegeforen. 2002;122:2546–2549. [PubMed] [Google Scholar]
- 30.Bakken IJ, Ariansen AMS, Knudsen GP, Johansen KI, Vollset SE. The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: Research potential of two nationwide health-care registries. Scand J Public Health. 2020;48:49–55. doi: 10.1177/1403494819859737. [DOI] [PubMed] [Google Scholar]
- 31.Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. doi: 10.1136/bmj.l869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Pineles BL, Park E, Samet JM. Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol. 2014;179:807–823. doi: 10.1093/aje/kwt334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril. 2008;90:714–726. doi: 10.1016/j.fertnstert.2007.07.1290. [DOI] [PubMed] [Google Scholar]
- 35.Feodor Nilsson S, Andersen PK, Strandberg-Larsen K, Nybo Andersen AM. Risk factors for miscarriage from a prevention perspective: A nationwide follow-up study. BJOG. 2014;121:1375–1384. doi: 10.1111/1471-0528.12694. [DOI] [PubMed] [Google Scholar]
- 36.Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: A systematic review and meta-analysis. JAMA. 2014;311:1536–1546. doi: 10.1001/jama.2014.2269. [DOI] [PubMed] [Google Scholar]
- 37.Pineles BL, Hsu S, Park E, Samet JM. Systematic review and meta-analyses of perinatal death and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol. 2016;184:87–97. doi: 10.1093/aje/kwv301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lawn JE, et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet. 2016;387:587–603. doi: 10.1016/s0140-6736(15)00837-5. [DOI] [PubMed] [Google Scholar]
- 39.Stephansson O, Petersson K, Björk C, Conner P, Wikström A-K. The Swedish Pregnancy Register—for quality of care improvement and research. Acta Obstet Gynecol Scand. 2018;97:466–476. doi: 10.1111/aogs.13266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Magnus MC, Morken NH, Wensaas KA, Wilcox AJ, Håberg SE. Risk of miscarriage in women with chronic diseases in Norway: A registry linkage study. PLoS Med. 2021;18:e1003603. doi: 10.1371/journal.pmed.1003603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Epelboin S, et al. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study. PLoS Med. 2021;18:e1003857. doi: 10.1371/journal.pmed.1003857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Regan AK, Arah O, Fell DB, Sullivan SG. SARS-CoV-2 infection during pregnancy and associated perinatal health outcomes: A national US cohort study. J Infect Dis. 2021 doi: 10.1093/infdis/jiab626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Donati S, Corsi E, Maraschini A, Salvatore MA. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: A national prospective population-based cohort study. BJOG. 2022;129:221–231. doi: 10.1111/1471-0528.16980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Stephansson O, et al. SARS-CoV-2 and pregnancy outcomes under universal and non-universal testing in Sweden: Register-based nationwide cohort study. BJOG. 2022;129:282–290. doi: 10.1111/1471-0528.16990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kharbanda EO, et al. Spontaneous abortion following COVID-19 vaccination during pregnancy. JAMA. 2021;326:1629–1631. doi: 10.1001/jama.2021.15494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Magnus MC, et al. Covid-19 vaccination during pregnancy and first-trimester miscarriage. N Engl J Med. 2021 doi: 10.1056/NEJMc2114466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zauche LH, et al. Receipt of mRNA covid-19 vaccines and risk of spontaneous abortion. N Engl J Med. 2021;385:1533–1535. doi: 10.1056/NEJMc2113891. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The individual-level data that support the findings of this study are not publicly available due to legal restrictions in all three Scandinavian countries. The analytical code can be accessed by contacting the corresponding author.